Citigroup’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-100,000
Closed -$910K 6544
2022
Q1
$910K Buy
+100,000
New +$1.15M ﹤0.01% 3061
2020
Q1
Sell
-400
Closed -$2K 7731
2019
Q4
$2K Sell
400
-900
-69% -$4.58K ﹤0.01% 7556
2019
Q3
$7K Buy
1,300
+300
+30% +$1.68K ﹤0.01% 7219
2019
Q2
$6K Sell
1,000
-4,300
-81% -$30.2K ﹤0.01% 7446
2019
Q1
$38K Sell
5,300
-4,400
-45% -$31.8K ﹤0.01% 6561
2018
Q4
$72K Sell
9,700
-3,800
-28% -$24.1K ﹤0.01% 5937
2018
Q3
$73K Buy
13,500
+2,300
+21% +$9.87K ﹤0.01% 6201
2018
Q2
$40K Buy
11,200
+1,700
+18% +$4.72K ﹤0.01% 6455
2018
Q1
$19K Sell
9,500
-400
-4% -$1.04K ﹤0.01% 6769
2017
Q4
$26K Buy
9,900
+9,400
+1,880% +$32.9K ﹤0.01% 6593
2017
Q3
$3K Sell
500
-600
-55% -$2.58K ﹤0.01% 6959
2017
Q2
$4K Buy
1,100
+500
+83% +$2.02K ﹤0.01% 6816
2017
Q1
$3K Buy
600
+400
+200% +$1.96K ﹤0.01% 6932
2016
Q4
$1K Sell
200
-4,800
-96% -$34.9K ﹤0.01% 7119
2016
Q3
$45K Sell
5,000
-3,000
-38% -$25.1K ﹤0.01% 5731
2016
Q2
$56K Buy
+8,000
New +$73.1K ﹤0.01% 5499

Other funds holding PACB